Interpretation According to Clone-Specific PD-L1 Cutoffs Reveals Better Concordance in Muscle-Invasive Urothelial Carcinoma

Because immune checkpoint inhibitors have been approved for treating advanced urothelial carcinoma (UC), programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) assays have been widely used as companion or complementary diagnostic tests for predicting treatment outcomes. Because different clone...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tzu-Hao, Cheng, Wei, Wang, Yeh-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998202/
https://www.ncbi.nlm.nih.gov/pubmed/33807802
http://dx.doi.org/10.3390/diagnostics11030448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998202/
https://www.ncbi.nlm.nih.gov/pubmed/33807802
http://dx.doi.org/10.3390/diagnostics11030448

Ejemplares similares